Low-risk prostate cancer

被引:0
|
作者
Stief, C. G. [1 ]
Roosen, A. [2 ]
机构
[1] Univ Munich, Urol Klin & Poliklin, D-81377 Munich, Germany
[2] Univ Munich, Urol Klin Grosshadern, D-81377 Munich, Germany
来源
UROLOGE | 2014年 / 53卷 / 07期
关键词
D O I
10.1007/s00120-014-3522-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1030 / 1030
页数:1
相关论文
共 50 条
  • [41] Dutasteride and active surveillance of low-risk prostate cancer
    Fleshner, Neil E.
    [J]. LANCET, 2012, 379 (9826): : 1590 - 1590
  • [42] Utilization of Prostate Brachytherapy for Low-Risk Prostate Cancer: Is the Decline Overstated?
    Safdieh, J.
    Schwartz, D.
    Osborn, V.
    Wong, A. T.
    Weiner, J. P.
    Schreiber, D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E242 - E243
  • [43] Low-risk prostate cancer and low testosterone: What are the acceptable alternatives?
    Soloway M.
    [J]. Current Urology Reports, 2009, 10 (6) : 413 - 417
  • [45] Prostate cancer: Long-term outcomes of SBRT in low-risk prostate cancer
    Ray K.
    [J]. Nature Reviews Urology, 2011, 8 (4) : 174 - 174
  • [46] Parallels Between Low-Risk Prostate Cancer and Thyroid Cancer A Review
    Ho, Allen S.
    Daskivich, Timothy J.
    Sacks, Wendy L.
    Zumsteg, Zachary S.
    [J]. JAMA ONCOLOGY, 2019, 5 (04) : 556 - 564
  • [47] Is Low-risk Prostate Cancer Really Low-risk? Consider Factors Affecting Biochemical Recurrence and Tumour Upgrade
    Sogutdelen, Emrullah
    Citamak, Burak
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (02): : 193 - 198
  • [48] Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers
    Dijkstra, Siebren
    Hamid, Agus Rizal A. H.
    Leyten, Giseleh. J. M.
    Schalken, Jack A.
    [J]. PROSTATE CANCER, 2012, 2012
  • [49] Low-risk Prostate Cancer Prior to or After Kidney Transplantation
    Stoeckle, Michael
    Junker, Kerstin
    Fornara, Paolo
    [J]. EUROPEAN UROLOGY FOCUS, 2018, 4 (02): : 148 - 152
  • [50] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    [J]. CANCER, 2018, 124 (01) : 55 - 64